To gain further insight into the origin of dysfunctional activity of HDL in Mb patients, the next step focused on investigating if M. leprae can modulate the expression of ApoA-I in hepatic cells since the liver is responsible for ApoA-I biosynthesis and reports are indicating hepatic alterations in leprosy [52, 53]. The gene discussed is MB; the disease is leprosy.